Welcome to CDC stacks | Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009 - 18400 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
  • Published Date:
    Mar 2011
  • Source:
    Emerg Infect Dis. 17(3):566-567.
Filetype[PDF-94.68 KB]


No Related Documents.
You May Also Like:
  1. Diagnosis and Treatment of Tuberculosis in the Private Sector, Vietnam
    Personal Author:
    Hoa, Nguyen B.; Cobelens, Frank G.J.; Sy, Dinh N.; Nhung, Nguyen V.; Borgdorff, Martien W.; Tiemersma, Edine W.;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):562-566.
    File Type:
    Filetype[PDF - 101.37 KB]
  2. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
    Personal Author:
    Osman, Muhammad; Harausz, Elizabeth P.; Garcia-Prats, Anthony J.; Schaaf, H. Simon; Moore, Brittany K.; Hicks, Robert M.; Achar, Jay; Amanullah, Farhana; Barry, Pennan; Becerra, Mercedes; Chiotan, Domnica I.; Drobac, Peter C.; Flood, Jennifer; Furin, Jennifer; Gegia, Medea; Isaakidis, Petros; Mariandyshev, Andrei; Ozere, Iveta; Shah, N. Sarita; Skrahina, Alena; Yablokova, Elena; Seddon, James A.; Hesseling, Anneke C.;
    Corporate Author:
    for The Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB
    Published:
    Mar 2019
    Source:
    Emerg Infect Dis. 25(3):441-450
    Description:
    Extensively drug-resistant tuberculosis (XDR TB) has extremely poor treatment outcomes in adults. Limited data are available for children. We report on clinical manifestations, treatment, and outcomes for 37 children (<15 years of age) with bacteriol...
    File Type:
    Filetype[PDF - 961.79 KB]
  3. Enteric fever treatment failures: a global concern.
    Personal Author:
    Chandel, D. S.; Chaudhry, R.;
    Published:
    2001 Jul-Aug
    Source:
    Emerg Infect Dis. 7(4):762-763.
    File Type:
    Filetype[PDF - 40.91 KB]
  4. New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
    Personal Author:
    Malik, Seidu; Willby, Melisa; Sikes, David; Tsodikov, Oleg V.; Posey, James E.;
    Published:
    Jun 28 2012
    Source:
    PLoS One. 2012; 7(6).
    Description:
    Fluoroquinolone antibiotics are among the most potent second-line drugs used for treatment of multidrug-resistant tuberculosis (MDR TB), and resistance to this class of antibiotics is one criterion for defining extensively drug resistant tuberculosis...
    File Type:
    Filetype[PDF - 407.03 KB]
  5. Hepatitis A Associated with Semidried Tomatoes, France, 2010
    Personal Author:
    Gallot, Céline; Grout, Lise; Roque-Afonso, Anne-Marie; Couturier, Elisabeth; Carrillo-Santisteve, Paloma; Pouey, Jérôme; Letort, Marie-José; Hoppe, Stéphanie; Capdepon, Pascal; Saint-Martin, Sylvie; De Valk, Henriette; Vaillant, Véronique;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):566-567.
    File Type:
    Filetype[PDF - 88.14 KB]